As the population ages, the risk of Alzheimer’s disease (AD) is elevated and the need for new approaches to management increases.1

AD is a burden for patients, caregivers, and the healthcare system1

An estimated 5.8 million Americans over the age of 65 are living with dementia due to AD. That number is projected to reach 13.8 million by 2050.1

Alzheimer’s Disease Prevalence and Economic Data by State1

Alabama iconAlabama

Projected Number of Patients:

In 2020

In 2025

Survey from 2019



$4.58 billion

Value of Unpaid Care*

*State totals may not add to the US total due to rounding.

In 2020, direct costs for Alzheimer's disease and other dementias are estimated at $305 billion1

On a yearly basis, the costs for Medicare/Medicaid beneficiaries with AD dementia or other dementias for healthcare services like hospitals, nursing homes, hospice, and home healthcare are significantly greater than for people without dementia.

If left unaddressed, total annual payments for healthcare, long-term care, and hospice care for people with AD and other dementias are projected to increase to more than $1.1 trillion in 2050.

Increased prevalence will place greater demands on healthcare providers1

Recent analysis suggests that the US has approximately half the number of geriatricians needed and that only a small percentage of nurse practitioners, social workers, and other professionals are skilled in working with older adults.

According to one estimate, the US is projected to need three times the current number of geriatricians by 2050.¹


An error occurred while rendering this component.

Please consult your application support team.

Preparing the healthcare infrastructure for the potential arrival of new treatment is an important next step for addressing the challenges of AD.

Request more information

Receive updated news and perspectives about Alzheimer’s disease

Enter a valid email address